Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Top Cited Papers
- 20 September 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 372 (9648), 1484-1492
- https://doi.org/10.1016/s0140-6736(08)61341-0
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemiaThe Journal of Experimental Medicine, 2008
- Trisomy of chromosome 21 in leukemogenesisBlood Cells, Molecules, and Diseases, 2007
- Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndromeBlood, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- Prediction of chromosomal aneuploidy from gene expression dataGenes, Chromosomes and Cancer, 2006
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Denaturing High-Performance Liquid Chromatography for the Detection of Mutations and Polymorphisms inUBE3AGenetic Testing, 2003
- An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinomaProceedings of the National Academy of Sciences of the United States of America, 2001